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Abstract 
Structural abnormalities involving sex chromosomes 
are uncommon in hematological malignancies. The 
unbalanced translocation between the long arm of 
chromosomes 1 and Y results in a partial trisomy of 
the 1q region and has been described mainly in 
chronic myeloproliferative disorders. 
Keywords 
Chronic myeloproliferative disorders; unbalanced 
translocation; genomic gains; disease evolution. 
Clinics and pathology 
Disease 
Myeloid disorders mainly, rarely B-cell lymphoid 
malignancies. 
Note 
 Chronic myeloid neoplasm  in 15 patients (15 
males aged 15 to 75 years; median 63 years). Among 
them, there were 7 cases of myelodysplastic 
syndrome (MDS) (Hollings et al., 1988; Thompsonet 
al., 1991; Wei et al., 1993; Raymakersetal et 
al.,1996; Djordjevicet al., 2008; Wan et al., 2001; 
Sanford et al., 2015), 1 polycythemia vera (Testa et 
al., 1981), 1 idiopathic myelofibrosis (Michaux et a., 
l 1996), 1 post-polycythemic myelofibrosis 
(Manabe et al., 2013), 1 essential thrombocythemia 
(Lim et al.,2016), 3 chronic myelomonocytic 
leukemia (Hollings et al., 1988;  Michaux et al., 
1996;  Chen et al., 2010) and  1 atypical chronic 
myeloid leukemia  (Ohsaka  Hisa  
2002). 
Acute myeloid leukemia  in 5 (aged 0 to 86 years, 
median 63 years): 2 acute myeloblastic leukemia 
with maturation (AML-M2) (Haupt et al., 1991; 
Singh et al., 1993), 2 acute myelomonocytic 
leukemia (AML- M4) (Bao et al., 2006; Brown et al., 
2012) and 1 acute monoblastic leukemia (AML-M5) 
(Tuborgh et al., 2013). ).  
 Acute lymphoblastic leukemia  in 2 pediatric 
patients aged 0 and 10 years (Dayton et al.,1994; 
Heerema et al., 1999). ).  
 Multiple myeloma  in 3 (1 aged 73 years, 2 
unknown age) (Mugneret et al., 1995; Wang et al., 
2010; Sawyer et al., 2014) and).  
 Mature B-cell neoplasm  in 4 (aged 10,11,36 and 
60 years) (Tanaka et al., 1990;  Dayton et al., 1994; 
Lones et al., 2004; Havelange et al., 2013). 
Epidemiology 
About 28 male patients harboring der(Y)t(Y;1)(q11-
12;q12-21) have been reported (aged 1 to 86 years, 
median 60 years). Among them, there were 7 
pediatric patients aged 0 to 15 years (median 10 
years). 
Prognosis 
The acquisition of an unbalanced 1q rearrangement 
in patients with myeloid malignancies appears to be 
a late event associated with disease transition and 
poor response to treatment. der(Y)t(Y;1) in multiple 
myeloma and lymphoid malignancies is part of 
complex karyotypes with coexisting other high-risk 
genetic abnormalities such as 11q23 and 8q24 
rearrangements that have an additional impact 
leading to shorter survival in these patients. 
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Figure 1.  Partial karyotypes showing the unbalanced rearrangement between chromosome Y and 1. Fluorescence hybridization 
with LSI X/Y probe (Abott molecular/Vysis, US) showing the der(Y) chromosome (A) and 2 copies of the derivative chromosome 




Unbalanced translocation; a trisomic 1q juxtaposed 
to Yq12-21 replacing the terminal segment of 
chromosome Y. 
Additional anomalies 
Sole karyotype aberration in 10 patients, while it was 
accompanied by a limited number of additional 
chromosomal changes in 5 myeloid malignancies: 
+9 in 2 and +8, del(20q), del(11)(q13) sole cases. 
Found with 11q23 rearrangements as part of 
complex karyotypes in 2 AML patients. Association 
with t(8;14)(q24;q32)/8q24 rearrangement in 1 ALL 
in all the 4 patients with mature B-cell neoplasm; 
highly complex rearrangements in MM. 




Complete or partial trisomies of 1q are well-known 
in hematological malignancies, but involvements of 
sex chromosomes are uncommon. Among them, 
der(Y)t(Y;1)(q11-12;q12-21) is most common in 
chronic myeloproliferative disorders, but cases of 
other diseases, such as AML or Burkitt's lymphoma 
have also been reported. While it is unknown which 
genes on 1q are responsible for the development 
and/or progression of these diseases, it is likely that 
1q trisomy results in deregulation of several genes 
implicated in leukemogenesis. 
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